Prosecution Insights
Last updated: August 16, 2026

Chiesi Farmaceutici S.p.a.

8 pending office actions • 7 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 17 patents granted in the last 365 days

Portfolio Summary

8
Total Pending OAs
5
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
2
Due this month
2
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Due ≤ 30 days (2)Due ≤ 60 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (25%)
4
Medium (50%)
2
Easy (25%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (12%)
§101 + other1 (12%)
§103 only3 (38%)
§112 only1 (12%)
Double-patenting only1 (12%)
Double-patenting + other1 (12%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
62% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
25% of docket
1
Business / Other
12% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PADUA, NICO LAUREN 1 14.3% +30.7%
ISLAM, MOHAMMAD K 1 82.9% +16.9%
ARNOLD, ERNST V 1 48.1% +12.9%
MELLER, MICHAEL V 1 47.2% +28.1%
GONZALEZ, LUISALBERTO 1 61.2% +44.9%
MEYERS, ELIZABETH ANNE 1 28.6% +90.9%
BASQUILL, SEAN M 1 38.8% +21.6%
JANG, JAEICK 1 66.7% +51.4%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18704352 APPARATUS AND METHOD FOR USING A PRODUCT HAVING AN IN-USE EXPIRY DATE PADUA, NICO LAUREN 53d
18704036 APPARATUS FOR ADMINISTERING MEDICAMENTS AND METHOD FOR MANAGING EXPIRY DATES OF A MEDICAMENT DISPENSER ISLAM, MOHAMMAD K
18203381 Pharmaceutical Compositions and Methods for Stabilizing the Same MEYERS, ELIZABETH ANNE

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17801067 PRESSURISED METERED DOSE INHALERS COMPRISING A BUFFERED PHARMACEUTICAL FORMULATION JANG, JAEICK 12d
18631588 CLEVIDIPINE EMULSION FORMULATIONS CONTAINING ANTIMICROBIAL AGENTS ARNOLD, ERNST V 30d
18551942 8-CYCLO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS GONZALEZ, LUISALBERTO 48d
18704352 APPARATUS AND METHOD FOR USING A PRODUCT HAVING AN IN-USE EXPIRY DATE PADUA, NICO LAUREN 53d
18576170 PROCESS FOR THE PREPARATION OF A PULMONARY SURFACTANT MELLER, MICHAEL V 69d
18704036 APPARATUS FOR ADMINISTERING MEDICAMENTS AND METHOD FOR MANAGING EXPIRY DATES OF A MEDICAMENT DISPENSER ISLAM, MOHAMMAD K
18203381 Pharmaceutical Compositions and Methods for Stabilizing the Same MEYERS, ELIZABETH ANNE
18030153 A PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER BASQUILL, SEAN M

Top Art Units

Art UnitApps
3626 1
1613 1
1655 1
1624 1
1622 1
1614 1
3785 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18704352 APPARATUS AND METHOD FOR USING A PRODUCT HAVING AN IN-USE EXPIRY DATE PADUA, NICO LAUREN 3626 §101§103 Non-Final OA 53d Pending Apr 24, 2024
18704036 APPARATUS FOR ADMINISTERING MEDICAMENTS AND METHOD FOR MANAGING EXPIRY DATES OF A MEDICAMENT DISPENSER ISLAM, MOHAMMAD K §101 Non-Final OA Pending Apr 23, 2024
18631588 CLEVIDIPINE EMULSION FORMULATIONS CONTAINING ANTIMICROBIAL AGENTS ARNOLD, ERNST V 1613 DP Final Rejection 30d Pending Apr 10, 2024
18576170 PROCESS FOR THE PREPARATION OF A PULMONARY SURFACTANT MELLER, MICHAEL V 1655 §103 Non-Final OA 69d Pending Jan 03, 2024
18551942 8-CYCLO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS GONZALEZ, LUISALBERTO 1624 §112 Non-Final OA 48d Pending Sep 22, 2023
18203381 Pharmaceutical Compositions and Methods for Stabilizing the Same MEYERS, ELIZABETH ANNE 1622 §112DP Non-Final OA Pending May 30, 2023
18030153 A PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER BASQUILL, SEAN M 1614 §103Other Final Rejection Pending Apr 04, 2023
17801067 PRESSURISED METERED DOSE INHALERS COMPRISING A BUFFERED PHARMACEUTICAL FORMULATION JANG, JAEICK 3785 §103 Final Rejection 12d Pending Aug 19, 2022

Managing Chiesi Farmaceutici S.p.a.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month